Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
JNJ PFE NVS SNY Beers Soft Drinks Restaurants Tech Funds 
United States  USA  |  Investing Themes


Processing
Processing. Please wait...

Biostar insider: Qinghua Liu

       

Qinghua Liu - Biostar Insider Profile

Interim CFO and Director

Ms. Qinghua Liu is Interim Chief Financial Officer, Director of Biostar Pharmaceuticals, Inc. She was appointed as Interim Chief Financial Officer of the Company effective as of December 18, 2012. Ms. Liu is currently a member of the Board of the Company. From January 2010 to present, Ms. Liu held the office of Assistant to the Chairman of the Board of the Company, Chief Financial Officer of Shaanxi Aoxing Pharmaceuticals Co., Ltd., and Supervisor of Shaanxi Biostar Biotech, Ltd. From March 2007 to January, Ms. Liu held the offices of Vice General Manager, Financial Manager, Chief Accountant and Director of Shaanxi Aoxing Pharmaceuticals Co., Ltd. From January 1998 to March 2007, she was Financial Manager and Chief Accountant of Shaanxi Aoxing Pharmaceuticals Co., Ltd. Ms. Liu holds a degree in Auditing and Financial Management from Northwest Institute of Light Industry, PRC.
  Director Since 2012      

Other Appointments

BIOSTAR PHARMA7BNAGermany Frankfurt
Director since 2012

Management Efficency

The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (29.81) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 4.76 M in liabilities with Debt to Equity (D/E) ratio of 0.08 which may suggest the company is not taking enough advantage from borrowing. Biostar Pharmaceuticals Inc has Current Ratio of 3.23 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
    

Other Executives

Zhongyang Shang, Chairman
Ronghua Wang, Chairman
Haipeng Wu, Chairman
Zibing Pan, CFO, MBA
Zhenghong Wang, COO
King-fai Leung, Director, CPA
King Leung, Director, CPA
Zack Pan, Executive
Shuang Gong, Executive

Entity Summary

Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of overthecounter and prescription pharmaceutical solutions for various diseases and conditions in the People?s Republic of China. Biostar Pharmaceuticals Inc [BSPM] is traded on NASDAQ General Markets in USA. It is located in Biostar Pharmaceuticals, Inc.Xianyang City, and employs 504 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
BSPM United States Nasdaq
Biostar Pharmaceuticals Inc
Currency: USD - US Dollar
Traded on NASDAQ General Markets
    
    
Chance of
Bankruptcy
Less
Than
47%
In The Next
Two Years
Biostar Pharmaceuticals Inc has less than 47.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Biostar price boundaries

    
May 10 2013
 0.74 
  
 0.67 
(0.07)  Macroaxis: -9.459459459459453 Down   9.46%  
Lowest period price (30 days)
April 30 2013
 0.90 
  
 0.87 
(0.03)  Macroaxis: -3.333333333333336 Down   3.33%  
Highest period price (30 days)
    

Promote Biostar and Qinghua Liu

Follow Biostar with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Biostar to your reader
 

Today Change

 thisGreen BSPM BSPM agains markets  2.67 % Macroaxis: change 2.67 Moved Up  
 
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 

Stock Performance

Shares Outstanding9.99 M
Number of Shares Shorted25.68 K


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium